Login / Signup

BST2 promotes gastric cancer metastasis under the regulation of HOXD9 and PABPC1.

Jiaying LiPing YangLinjie HongWushuang XiaoLuyu ZhangZhen YuJieming ZhangMiaomiao PeiYing PengXiangyang WeiXiaosheng WuWeimei TangYingying ZhaoJuanying YangZhizhao LinPing JiangLi XiangHui ZhangJianjiao LinJide Wang
Published in: Molecular carcinogenesis (2024)
Gastric cancer (GC) constitutes substantial cancer mortality worldwide. Several cancer types aberrantly express bone marrow stromal cell antigen 2 (BST2), yet its functional and underlying mechanisms in GC progression remain unknown. In our study, RNA sequencing data revealed that BST2 was transcriptionally activated by homeobox D9 (HOXD9). BST2 was significantly upregulated in GC tissues and promoted epithelial-mesenchymal transition and metastasis of GC. BST2 knockdown reversed HOXD9's oncogenic effect on GC metastasis. Moreover, BST2 messenger RNA stability could be enhanced by poly(A) binding protein cytoplasmic 1 (PABPC1) through the interaction between BST2 3'-UTR and PABPC1 in GC cells. PABPC1 promoted GC metastasis, which BST2 silencing attenuated in vitro and in vivo. In addition, positive correlations among HOXD9, BST2, and PABPC1 were established in clinical samples. Taken together, increased expression of BST2 induced by HOXD9 synergizing with PABPC1 promoted GC cell migration and invasion capacity.
Keyphrases